These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32660332)

  • 21. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis.
    Seresirikachorn K; Mullol J; Limitlaohaphan K; Asvapoositkul V; Snidvongs K
    Rhinology; 2021 Feb; 59(1):2-9. PubMed ID: 32692787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessments.
    Verkerk MM; Bhatia D; Rimmer J; Earls P; Sacks R; Harvey RJ
    Am J Rhinol Allergy; 2015; 29(1):3-18. PubMed ID: 25590306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. As-needed intranasal corticosteroid spray for allergic rhinitis: a systematic review and meta-analysis.
    Hoang MP; Chitsuthipakorn W; Seresirikachorn K; Snidvongs K
    Rhinology; 2022 Aug; 60(4):242-251. PubMed ID: 35379997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
    Castela E; Archier E; Devaux S; Gallini A; Aractingi S; Cribier B; Jullien D; Aubin F; Bachelez H; Joly P; Le Maître M; Misery L; Richard MA; Paul C; Ortonne JP
    J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():47-51. PubMed ID: 22512680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index.
    Daley-Yates PT; Larenas-Linnemann D; Bhargave C; Verma M
    J Asthma Allergy; 2021; 14():1093-1104. PubMed ID: 34526783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-sinus surgery insertion of steroid-eluting bioabsorbable intranasal devices: A systematic review.
    Rizan C; Elhassan HA
    Laryngoscope; 2016 Jan; 126(1):86-92. PubMed ID: 26154025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. As-needed versus regular intranasal corticosteroid for allergic rhinitis: A systematic review and meta-analysis.
    Phinyo P; Wongsa C; Sompornrattanaphan M; Thongngarm T
    Asian Pac J Allergy Immunol; 2022 Sep; 40(3):195-204. PubMed ID: 35278059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?
    Waddell AN; Patel SK; Toma AG; Maw AR
    J Laryngol Otol; 2003 Nov; 117(11):843-5. PubMed ID: 14670141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of study design on the evaluation of inhaled and intranasal corticosteroids' effect on hypothalamic-pituitary-adrenal axis function, part I: general overview of HPA axis study design.
    Fan Y; Ma L; Pippins J; Limb S; Xu Y; Sahajwalla CG
    J Pharm Sci; 2013 Oct; 102(10):3513-27. PubMed ID: 23918409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical intranasal corticosteroids and growth velocity in children: a meta-analysis.
    Mener DJ; Shargorodsky J; Varadhan R; Lin SY
    Int Forum Allergy Rhinol; 2015 Feb; 5(2):95-103. PubMed ID: 25367369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of intra-nasal corticosteroid spray in pediatric: Systematic review.
    AlTheyab F; Alkhodair A; Albdah A; Alanazi RK; Alkhodair A
    Am J Otolaryngol; 2024; 45(4):104355. PubMed ID: 38723378
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review.
    Hong J; Bielory B; Rosenberg JL; Bielory L
    Allergy Asthma Proc; 2011; 32(1):22-35. PubMed ID: 21262095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology, particle deposition and drug administration techniques of intranasal corticosteroids for treating allergic rhinitis.
    Rollema C; van Roon EN; van Boven JFM; Hagedoorn P; Klemmeier T; Kocks JH; Metting EI; Oude Elberink HNG; Peters TTA; San Giorgi MRM; de Vries TW
    Clin Exp Allergy; 2022 Nov; 52(11):1247-1263. PubMed ID: 35947495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
    Rollema C; van Roon EM; Schilder AG; de Vries TW
    BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic Cushing's Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case Report.
    Orton S; Censani M
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244810
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.